Align Technology, Inc.
NASDAQ•ALGN
CEO: Mr. Joseph M. Hogan
Sector: Healthcare
Industry: Medical - Devices
Listing Date: 2001-01-30
Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth. The segment also provides Invisalign moderate, lite and express packages, and Invisalign go and Invisalign Go Plus; retention products, Invisalign training, and adjusting tools used by dental professionals during the course of treatment; and Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and orthodontists software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers. This segment also provides Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface designed to enhance dental consultations; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan, as well as subscription software, disposables, rentals, leases, pay per scan, and CAD/CAM software solutions. The company was incorporated in 1997 and is headquartered in Tempe, Arizona.
Contact Information
Market Cap
$12.54B
P/E (TTM)
30.5
26.9
Dividend Yield
--
52W High
$208.31
52W Low
$122.00
52W Range
Rank24Top 10.8%
5.7
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Average • 5.7 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2016-2025
Financial Dashboard
Q4 2025 Data
Revenue
$1.05B+0.00%
4-Quarter Trend
EPS
$1.89+0.00%
4-Quarter Trend
FCF
$289.71M+0.00%
4-Quarter Trend
2025 Annual Earnings Highlights
Key Highlights
Total Revenue Growth Slight Total net revenues reached $4.04B USD, marking a 0.9% increase; Clear Aligner revenue grew 0.5% to $3.25B USD.
Systems Services Revenue Strong Systems and Services revenue increased 2.7% to $790M USD, driven by strong scanner wand sales volume growth.
Cash Position Strengthened Cash and cash equivalents ended 2025 at $1.09B USD, providing strong liquidity for operations and future investments.
New Product Enhancements Launched Announced restorative capabilities for iTero Lumina Pro and limited commercial availability of Invisalign MAOB system.
Risk Factors
Operating Margin Compression Total operating margin fell to 13.5% from 15.2% due to lower gross margins and $4.2M legal settlement loss.
Restructuring and Asset Impairment Incurred $41M restructuring expenses; recognized $23.1M impairment loss on manufacturing assets classified as held for sale.
Clear Aligner ASP Decline Clear Aligner revenue per case shipment decreased 3.9% to $1,245 USD due to product mix shifts and discounts.
Macroeconomic Uncertainty Risks Continued exposure to foreign currency fluctuations, inflation, and geopolitical tensions impacting global demand and costs.
Outlook
International Expansion Focus Continue global presence growth, scaling operations and facilities across Americas, APAC, and EMEA regions through 2026.
R&D Investment in AI Investing in AI infrastructure and strategic partnerships to enhance the Align Digital Platform capabilities and operational efficiency.
Drive GP Utilization Rates Focus on training more GPs and increasing utilization rates, targeting teens and adults for Invisalign adoption globally.
Managing Restructuring Impacts Expect additional costs from 2025 restructuring plan; managing manufacturing footprint optimization and workforce realignment.
Peer Comparison
Revenue (TTM)
$13.64B
$13.18B
$5.06B
Gross Margin (Latest Quarter)
95.6%
72.0%
68.0%
Key Metrics
Symbol | Market Cap | P/E (TTM) | ROE (TTM) | Debt to Assets |
|---|---|---|---|---|
| PEN | $13.19B | 74.1 | 13.4% | 12.0% |
| ALGN | $12.54B | 30.5 | 10.4% | 1.8% |
| ENSG | $12.23B | 35.2 | 16.6% | 76.1% |
Long-Term Trends
Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
2.3%
Moderate Growth
4Q Net Income CAGR
13.3%
Profitability Improving
Cash Flow Stability
100%
Strong Cash Flow
Deep Research
Next earnings:Apr 28, 2026
EPS:-
|Revenue:-
Financials
Earnings Calls
Reports
News
Income Statement
Balance Sheet
Cash Flow Statement
Ratios
% Chg.
Income Statement | LTM |
|---|
No Data